In a resting-state fMRI study of adults with episodic migraine, chronic migraine, and healthy controls, migraine was associated with reduced brain entropy, with partial entropy restoration during attacks.
...
Featured faculty at The Revolution & Paradigm Shift in Treatment of Migraine, scheduled for July 16-17, 2026, will highlight evolving approaches to migraine diagnosis, prevention, disease burden, and...
Several sessions at the 2026 American Association of Nurse Practitioners National Conference in Las Vegas, NV, addressed migraine-related diagnosis, treatment, red flags, and care considerations across...
Basic Science Award recipient Alberto Ouro, PhD, presented his team’s cross-sectional study at the American Headache Society 68th Annual Scientific Meeting in Orlando, FL. The award recognizes the top basic...
A 1-year interim analysis of a phase 3, multicenter, open-label, 156-week extension study found overall reductions in systolic and diastolic blood pressure with atogepant 60 mg once daily in persons with...
In an Early Career Lecture Award study presented at the American Headache Society 68th Annual Scientific Meeting, nitroglycerin provoked headache and vestibular symptoms in participants with definite...
At the 2026 American Academy of Neurology Annual Meeting in Chicago, IL, investigators presented real-world evidence evaluating whether glucagon-like peptide-1 receptor agonists influence healthcare...
Recent studies in children and adults associate long COVID with worsened academic performance, attention difficulties, subjective cognitive impairment, and persistent neurologic and psychiatric symptoms.
...
The FDA has approved Avlayah (tividenofusp alfa-eknm) for certain pediatric patients with Hunter syndrome, marking the first approval targeting the disease's neurologic complications and offering clinicians...
